Background: The role played by Helicobacter pylori in the sinuses, and its association with the same organism's gastric infection, are still unclear.
Introduction
Helicobacter pylori DNA has been detected in a number of extragastric locations, such as the oral cavity, tonsils and adenoids (1, 2) , and even the middle ear and paranasal sinuses (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . However, the significance of the microorganism's presence at these aero-digestive and respiratory sites is still unclear. It is believed that the oral cavity is an important reservoir for H. pylori, that contributes to the oral-oral route of transmission and acts as a source of stomach re-infection (1) . Others suggest that the bacterium may be capable of causing damage to the aero-digestive and respiratory mucosa in the same way it does to the gastric mucosa (1) . However, this capacity for extra-gastric disease remains unproved, and some authors argue that it even seems unlikely.
In order to initiate tissue damage, not only does H. pylori require a set of events unique to the gastric milieu, but also culturable active forms of H. pylori have only been recovered outside the stomach in the aero-digestive tract in the vicinity of the upper esophagus (i.e. in tracheal secretions in intubated patients), and never as far away as the bronchi, lung, or the upper respiratory tract (2) . That far from the stomach, only the microorganism's DNA suggests the presence of H. pylori at such locations.
We conducted the present investigation in order to see how H. pylori colonization patterns in the nose and stomach are associated in chronic rhinosinusitis patients, as a way to also provide information on the eventual existence of an interaction between two seemingly unconnected pathologies, one in the digestive tract and the other in the upper respiratory tract. At the same time, we assessed if this known gastric pathogen has the capacity to also inflict direct injury to the sinus mucosa.
Materials and Methods

Patients
A total of 14 adult patients, 8 male and 6 female, aged 30 to 68 years (mean 48.1 years), requiring endoscopic sinus surgery due to medically recalcitrant chronic rhinosinusitis, with and without nasal polyposis, were enrolled in a consecutive, unselected manner. Informed consent was obtained from each patient, and the study protocol was approved by the institutional ethics committee. All patients had their biochemical and hematological profiles within the normal range, with the exception of mild-tomoderate eosinophilia in some atopic patients. Patients with cystic fibrosis, immotile cilia syndrome, and known immunodeficiencies were excluded. The inflammatory nature of the disease was subsequently confirmed by histopathologic examination in all patients enrolled.
Drug therapy for any underlying condition was allowed, including systemic steroids for asthma management. Antibiotic use in the 3 months prior to surgery was also noted. Moreover, patients were specifically asked about their history of prior H. pylori infection diagnosis and treatment, as well as current medication with antacids, histamine 2 -receptor antagonists, prokinetic agents, or proton-pump inhibitors (PPI's).
Procedures
In the immediate pre-operative period (from 1 to 10 days preop), all subjects underwent a 13C-labelled urea breath test.
Surgery was performed under general anesthesia, with orotracheal intubation. Routine vasoconstriction of the nasal mucosa was carried out to minimize intra-operative bleeding, including infiltration, at critical sites, with 1% xylocaine with 1:100,000 epinephrine.
The extent of the pathology on the computed tomography scans determined which sites were to be surgically approached.
All patients required bilateral procedures due to roughly symmetrical extension of the pathology, according to the Lund-McKay classification (16) . During surgery, tissue samples of diseased sinonasal mucosa were collected at the anterior ethmoid (including the uncinate process, ethmoidal bulla, and meatal portion of the middle turbinate), and the posterior ethmoid sinus from one, randomly chosen, nasal cavity. The collected sinus specimens were subjected to: 1) histopathological examination, to assess the overall degree of local inflammation (graded as 0+, no inflammation; 1+, mild; 2+, moderate; and 3+, severe inflammation, depending on the inflammatory infiltrate cell density (17) );
2) microbiological culture, to isolate H. pylori; and 3) polymerase chain reaction (PCR) to amplify genomic H. pylori DNA. 
Polymerase chain reaction
For PCR testing, two sets of primers targeting the 16S rRNA and 23S rRNA genes of H. pylori were used, chosen to maximize detection as together they target sequences common to virtually all H. pylori strains (18, 19) . The first primer pair, PCR-G, amplifies a 780bp fragment from the 16S rRNA gene specific for the Helicobacter genus, Helico F -5' CTATGACGGGTATCCGGC 3' and Helico R -5' CTCACGACACGAGCTGAC 3' (18) . The second primer pair, PCR-S, amplifies a 267 bp fragment from the 23S rRNA gene of the H. pylori, HPYS -5´ CGCATGATATTCCCATTAGCAGT 3' and HPYA -5' AGGTTAAGAGGATGCGTCAGTC 3' (19) . Ethidium bromide-stained agarose gel electrophoresis was employed for separating the PCR products according to their size. When interpreting the results, we considered a positive genus-specific PCR test a sign of presence of DNA for one of the various Helicobacter species, whilst the combination of a positive genus-specific with a positive species-specific PCR test was taken as a clear sign of presence of the actual H. pylori species. 
Histology
For histological identification of H. pylori in paraffin sections of sinus tissue, the modified Warthin-Starry silver staining kit (Merck, Germany) was used.
The grading of the histological material, as well as all the molecular biology procedures, were performed after the identification of the samples was masked.
Statistics
Statistical analysis employed descriptive statistics and the Spearman's rank correlation coefficient (Spearman's rho).
Results
The study group included 8 patients with asthma, 6 with allergic rhinitis, and 2 with intolerance to nonsteroidal anti-inflammatory drugs (NSAIDs). Other co-morbidities included: hypertension (n=2), hypothyroidism (n=1), goiter (n=1), angioma of the liver (n=1), ankylosing spondylitis (n=1), fibromyalgia while on NSAID's (n=1), gastroesophageal reflux disease (GERD) (n=2) and chronic gastritis (n=1). Two patients were undergoing revision sinus surgery, and three admitted having taken an oral antibiotic in the immediate three months prior to surgery. One subject had history of H. pylori gastric infection treatment, while five Neg=negative result. Pos=positive result. Inflammation grade: 0+= no inflammation; 1+= mild inflammation; 2+=moderate inflammation; 3+=severe inflammation. H. pylori histology: 0=no bacteria found; 1+=low density of bacteria; 2+= moderate density of bacteria; 3+=high density of bacteria.
H. pylori PCR: G-genus pair of primers; S-species pair of primers. NA= data not available. were taking a PPI until the day before surgery. The patient with ankylosing spondylitis was under treatment with sulfasalazine at the time of the surgical procedure, and the stiffness of his entire spine was so severe that the gastroenterologist was unable to perform the required gastroduodenal endoscopy, even under general anesthesia. Another patient underwent upper gastrointestinal endoscopy outside of the time frame imposed by the strict study criteria (either intra-op or up to two weeks post sinus surgery), so the gastric results were excluded from the analysis.
Patient
Two patients had histology results for one gastric site only, and in one patient the gastric histological results were altogether absent.
The inflammatory status of the sinus mucosa at the time of surgery for each patient is displayed in Table 1 . Severe inflammation was not encountered in any subject; moderate inflammation was found in 50% (n=5) of the asthmatics and in 16.6 % (n=1) of the non-asthmatics, whilst mild inflammation was encountered in 50% (n=4) of the asthmatics and in 83.3 % (n=5) of the non-asthmatics. A total of 60% (n=3) of patients in the moderate sinus inflammation group had allergic rhinitis, while mild inflammation was observed in 50% (n=3) of the patients with a diagnosis of allergic rhinitis. All patients with intolerance to NSAIDs in the study group displayed moderate sinus inflammation.
Moderate sinus inflammation was also encountered in 66.7% (n=2) of the patients who had taken an antimicrobial agent in the three months prior to surgery, whilst mild inflammation was mostly found (72.7%, n=8) in patients who had not recently needed antibiotic treatment.
The only patient who had prior treatment for H. pylori gastric infection displayed moderate sinus inflammation, while, among the five patients who were on PPI's at the time of surgery, three showed mild sinus inflammation and two moderate sinus inflammation. Table 1 shows the results of the gastric and nasal inflammatory and H. pylori infection status for all patients.
All patients were found to have some degree of gastric inflammation, fitting the histopathological diagnosis of chronic non-atrophic gastritis (active or non-active), even when the endoscopist failed to identify inflammation and performed iterative biopsies. A total of 60% of the antrum biopsies showed moderate inflammation, with mild inflammation occurring in 40%, whereas in corpus biopsies 70% had mild and 30% moderate inflammation.
Histological identification of H. pylori in gastric mucosa biopsies of the antrum was negative in 50% of the cases (n=5), revealing mild infection in 10% (n=1), moderate infection in 10% (n=1), and severe infection in 30% of the cases (n=3). For the corpus biopsies, the results were negative in 50% (n=5), with mild infection in 10% (n=1), moderate in 30% (n=3), and severe infection in 10% (n=1).
The results of cultures of gastric mucosa biopsies were positive for H. pylori in 66.7% of the cases (n=8), whilst the PCR-G test was positive in 54.5% (n=6) of the antrum samples and in 50%
(n=5) of the corpus samples, and the PCR-S test was positive in 72.7% (n=8) of the antrum samples and in 66.7% (n=8) of the corpus samples.
A total of 66.6% of the patients receiving PPI treatment were H.
pylori negative. culture, but the species-specific PCR identification test in the stomach was positive (result confirmed at a different laboratory).
All attempts to grow H. pylori in culture medium from sinonasal samples failed.
Discussion
The characteristics of our investigation, with patients undergoing simultaneous extensive sinus and stomach tissue sampling, and with various tests concurrently performed, necessarily restricts the number of patients enrolled in the study, and as a result may not be able to show statistical significance. The available data, however, are sufficient to allow for important conclusions.
Since urease production is a hallmark of active gastric infection, it is perhaps no surprise that most, but not all, patients in our study with a positive urease breath test had indeed H. pylori gastric infection, confirmed by histopathology, culture, and/or PCR testing. The breath test was positive in one case where H.
pylori was detected in the sinuses, but was negative in the other.
As the majority of patients in our study had positive breath tests and no evidence of H. pylori in their sinuses, this apparently renders the test unsuitable for the specific identification of the bacterium in the nose.
Our data actually reveals that, in spite of the relevant number of patients with positive Helicobacter-genus DNA detected by PCR in the sinus mucosa (which certainly merits separate investigation), specifically H. pylori DNA was only found in the sinonasal mucosa of about 15.4% of chronic rhinosinusitis surgical patients. These results are in agreement with previously published data (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Admittedly, this prevalence could indeed be greater if the bacterium in the nose would follow a similar mosaic pattern of mucosal infection as in the stomach, with patches of diseased mucosa alternating with non-infected normal mucosa, in which case it would require repeated and extensive sampling to allow for a positive H. pylori result (five different sites, according to some) (20) . (2) . So it is admissible that the reason may not have to do with the method but with the possibility that, in the sinuses, either the organism is represented just by fragments of its DNA and that these are destined to transiently remain there just for a limited time, or the microorganism is, in fact, in a dormant state that precludes culture, and is destined to remain for a long time in the sinuses.
The bacterium is, indeed, known to be able to resist harsh environments by changing to a dormant, inactive state, a non-culturable coccoid form that could still be potentially viable, later on, in the stomach (21, 22) . It is therefore possible that H. pylori may lay dormant for long periods of time, using the nose and the sinuses as reservoirs, waiting for an eventual return to an active form, either to cause gastric re-infection or to participate in the oral-oral route of transmission. The fact that in a previous study no statistical difference was observed between H. pylori nasal colonization in patients with sinusitis when compared to the control group (6) , lends credibility to the 'nose as a reservoir' thesis, and reinforces our conviction that the bacterium's presence in the nose does not contribute to the local inflammatory status.
To account for the bacterium's presence in the nose, the hypothesis of gastric-nasal transmission seems the most logical explanation since a significant number of patients with GERD and laryngopharyngeal reflux (LPR) also have H. pylori gastric colonization. It has been shown that the microorganism has a positive tropism for mucins (23) -and mucins cover and protect the sinus and mouth epithelia (24) -and is also able to invade epithelial cells (25) . (2) . Definitive proof of the clinical relevance of these H. pylori-induced systemic effects is, however, still lacking.
Conclusion
Our results suggest that, regardless of how H. pylori reaches the sinuses, its presence there does not seem to contribute to the local inflammatory status of the respiratory mucosa. The fact that H. pylori could not be cultured from nose samples and is only present in its DNA form, suggests either a transient presence of parts of its genome in the sinuses, or, instead, what could be seen as a defensive adaptive reaction in preparation for a more or less lengthy stay at an inhospitable location, a change to a viable non-culturable form, from which H. pylori could hypothetically regain activity, to either play a role in the oral-oral route of transmission or in an eventual gastric re-infection.
